Merck’s oral antiviral pill for COVID-19, molnupiravir — marketed under the name Lagevrio — may be fueling the development of new and potentially deadly variants of COVID-19, according to the authors of a new preprint study.
https://childrenshealthdefense.org/defender/merck-covid-pill-virus-mutations/
